Trials / Active Not Recruiting
Active Not RecruitingNCT04144387
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.
Evaluation of the Impact of the Update Multiple Myeloma Criteria on the Natural History of Smoldering Myeloma in Order to Establish New Recommendations About Follow-up and Prognostic Evaluation of Smoldering Myeloma (CARRISMM)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 395 (actual)
- Sponsor
- Intergroupe Francophone du Myelome · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.
Detailed description
In 2014, the International Myeloma Working Group (IMWG) proposed a revised classification of multiple myeloma (MM) and smoldering myeloma (SMM). Since the new definition of SMM proposed excludes "ultra-high risk SMM", the evolution profile of SMM will change. Therefore, investigators need to update their knowledge of SMM to optimize the management of patients. This project is expected to describe more precisely the new landscape of SMM. The results will help to establish new recommendations for the standard care of SMM and especially for defining accurate follow-up and risk stratifying.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Myelogram | Two additional myelograms will be performed comparing to standard of care. |
Timeline
- Start date
- 2020-02-11
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2019-10-30
- Last updated
- 2024-03-06
Locations
90 sites across 3 countries: Belgium, France, Monaco
Source: ClinicalTrials.gov record NCT04144387. Inclusion in this directory is not an endorsement.